These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 9551927)

  • 1. Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-gamma but requires TNF-alpha.
    White DW; Harty JT
    J Immunol; 1998 Jan; 160(2):898-905. PubMed ID: 9551927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive immunity and enhanced CD8+ T cell response to Listeria monocytogenes in the absence of perforin and IFN-gamma.
    Badovinac VP; Harty JT
    J Immunol; 2000 Jun; 164(12):6444-52. PubMed ID: 10843700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice.
    White DW; Badovinac VP; Kollias G; Harty JT
    J Immunol; 2000 Jul; 165(1):5-9. PubMed ID: 10861027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes.
    White DW; MacNeil A; Busch DH; Pilip IM; Pamer EG; Harty JT
    J Immunol; 1999 Jan; 162(2):980-8. PubMed ID: 9916723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.
    Prévost-Blondel A; Roth E; Rosenthal FM; Pircher H
    J Immunol; 2000 Apr; 164(7):3645-51. PubMed ID: 10725721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient anti-listerial immunity in the absence of perforin can be restored by increasing memory CD8+ T cell numbers.
    Messingham KA; Badovinac VP; Harty JT
    J Immunol; 2003 Oct; 171(8):4254-62. PubMed ID: 14530349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A knockout approach to understanding CD8+ cell effector mechanisms in adaptive immunity to Listeria monocytogenes.
    Harty JT; White D
    Immunobiology; 1999 Dec; 201(2):196-204. PubMed ID: 10631568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
    Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
    J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes.
    Berg RE; Crossley E; Murray S; Forman J
    J Immunol; 2005 Aug; 175(3):1751-7. PubMed ID: 16034116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
    Roth E; Pircher H
    J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class Ia MHC-deficient BALB/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection.
    D'Orazio SE; Halme DG; Ploegh HL; Starnbach MN
    J Immunol; 2003 Jul; 171(1):291-8. PubMed ID: 12817010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes.
    Jensen ER; Glass AA; Clark WR; Wing EJ; Miller JF; Gregory SH
    Infect Immun; 1998 Sep; 66(9):4143-50. PubMed ID: 9712760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells.
    Poehlein CH; Hu HM; Yamada J; Assmann I; Alvord WG; Urba WJ; Fox BA
    J Immunol; 2003 Feb; 170(4):2004-13. PubMed ID: 12574370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants.
    Bouwer HG; Gibbins BL; Jones S; Hinrichs DJ
    Infect Immun; 1994 Mar; 62(3):1039-45. PubMed ID: 7509313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listeriolysin O is a target of the immune response to Listeria monocytogenes.
    Bouwer HG; Nelson CS; Gibbins BL; Portnoy DA; Hinrichs DJ
    J Exp Med; 1992 Jun; 175(6):1467-71. PubMed ID: 1588276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.